BANDIT trial
Phase 3
Recruiting
- Conditions
- rectal neuroendocrine tumor
- Registration Number
- JPRN-jRCTs042210124
- Lead Sponsor
- Imai Kenichiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 266
Inclusion Criteria
Patients with rectal neuroendocrine tumors of <=10 mm in size
Exclusion Criteria
Local recurrence after previous polypectomy attempts
Inflammatory bowel disease, polyposis syndrome
Hematological abnormality
Active infectious disease
Hemodialysis
Infeasibility of suspending antithrombotic drugs
Pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method En bloc resection with histologically tumor-free margins
- Secondary Outcome Measures
Name Time Method (1) En bloc resection<br>(2) Mean procedure time<br>(3) Adverse events<br>(4) Length of hospital stay<br>(5) Cost analysis<br>(6) Adverse events on resection defect closure <br>(7) Outcomes between experts and non-expert endoscopists<br>(8) Risk factors for incomplete resection